Understanding Human Papillomavirus Infection

Human papillomavirus (HPV) is a large group of viruses affecting skin and mucosal tissue. Many infections cause no symptoms and clear naturally, while persistent infection with certain high-risk types can cause cell changes that may develop into cancer. Other types can cause genital warts.

Key Points

• HPV is common and may be present without symptoms.
• HPV status does not show when transmission occurred or identify a particular partner.
• Vaccination and cervical screening reduce risk but serve different purposes.
• Screening and vaccination eligibility depend on the current programme in the country where care is received.

What Is Human Papillomavirus?

HPV types are often described as low-risk or high-risk according to the conditions with which they are associated. Low-risk types may cause warts and are not the same as the high-risk types associated with precancerous cell changes and cancer.

HPV is common, but population figures vary by age, location, testing method and population. A positive result does not mean that cancer is present.

How HPV Can Be Transmitted

HPV can pass through close skin-to-skin contact involving the genital area and through vaginal, anal or oral sexual contact. Transmission can occur when no symptoms or visible warts are present.

Barrier methods may reduce exposure but do not cover every area of skin through which HPV can pass. Sharing sex toys without cleaning them or using a new barrier may also increase exposure.

Symptoms and Possible Effects

Many HPV infections have no symptoms. Some low-risk types can cause genital warts, while persistent high-risk infection may cause cell changes detected through an appropriate screening programme.

Visible growths, unexplained bleeding, pain, a persistent mouth or throat symptom, or another new concern should be assessed by a qualified clinician. These symptoms can have causes other than HPV.

Testing and Cervical Screening

HPV testing is used within cervical screening programmes and in selected clinical situations. It is not a general test for every HPV infection or every part of the body. A clinician can explain whether testing, examination or referral is appropriate.

Follow the current screening invitation and guidance for the country where you receive care. Screening is intended to identify high-risk HPV and/or cell changes before cancer develops; it does not replace assessment of symptoms.

Treatment of HPV-related Conditions

There is no treatment that directly removes every HPV infection. Management focuses on conditions caused by HPV, such as visible warts or abnormal cell changes, and on appropriate monitoring. The recommended method depends on the site, findings, medical history and local clinical guidance.

For information about assessment and treatment of visible warts, see the Revitalize genital wart treatment guide. A clinician should confirm the diagnosis before treatment because other conditions can look similar.

HPV Vaccination

HPV vaccination helps prevent infection with vaccine-covered HPV types and reduces the risk of cervical cancer and other HPV-related disease. It does not treat an existing infection and does not replace cervical screening.

Vaccine products, schedules and eligibility change over time and differ between countries. Check the current national immunisation programme or ask a qualified healthcare professional rather than relying on an age or dose schedule copied from an older article.

For current global information, see the World Health Organization cervical cancer fact sheet.

HPV and Cancer Risk

Persistent infection with oncogenic HPV types causes almost all cervical cancers and is associated with some anal, penile, vulval, vaginal and oropharyngeal cancers. Most HPV infections do not progress to cancer.

Risk depends on factors including HPV type, persistence, immune status, smoking and access to vaccination, screening and follow-up. A positive HPV result should be managed according to the relevant screening or clinical pathway.

Living with an HPV Result

HPV is common and a result cannot establish when transmission occurred. It should not be used to assign blame. Follow the advice given with the result and attend recommended screening, examination or follow-up.

If the result causes anxiety or affects relationships, a sexual-health clinician or counsellor can provide confidential support and help explain transmission and follow-up.

Prevention and Risk Reduction

Vaccination and participation in the relevant cervical screening programme are the main population-level prevention measures. Barrier methods may reduce exposure but do not eliminate it because HPV can affect uncovered skin.

Stopping smoking supports general health and may reduce factors associated with persistent HPV-related cell changes. Seek assessment for symptoms rather than waiting for a routine screening invitation.

Frequently Asked Questions

Does an HPV result mean I have cancer?

No. Most infections do not progress to cancer. Follow the screening or clinical advice provided so that persistent high-risk infection or cell changes can be monitored appropriately.

Can HPV be present without symptoms?

Yes. HPV can be present and transmitted when there are no visible warts or other symptoms.

Does vaccination replace cervical screening?

No. Vaccination and screening serve different purposes. Follow the current screening guidance for the country where you receive care.

Can genital warts be treated?

Visible warts can be assessed and treated, although they may recur. A clinician should confirm the diagnosis and discuss suitable options and side effects.